Astrazeneca Phar

Buy

Part of MomentumNow Stocks Strategy1+

Market Cap: Large Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE203A01020
NSEID: ASTRAZEN
BSEID: 506820

INR

8,388.95

385.05 (4.81%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 18.23 k

Click here to access the older version

Cash Flow

Astrazeneca Phar Cash flow Statement

Figures in Rs cr

Standaloned Cash Flow Results

Mar'24

Mar'23

Mar'22

Mar'21

Mar'20

Mar'19

Compare Cash Flow Results of Astrazeneca Phar

Select Peers

Figures in Rs cr

standaloned Cash Flow Results

Change(INR)

Change(%)

Profit Before Tax

219.54

2259.57

-2,040.00

-90.28%

Adjustment

-7.07

161.91

-168.00

-104.37%

Changes In working Capital

-128.17

-40.95

-88.00

-212.99%

Cash Flow after changes in Working Capital

84.3

2380.53

-2,296.00

-96.46%

Cash Flow from Operating Activities

27.87

1982.97

-1,955.00

-98.59%

Cash Flow from Investing Activities

21.74

-1919.22

1,940.00

101.13%

Cash Flow from Financing Activities

-44.38

-8.68

-36.00

-411.29%

Net Cash Inflow / Outflow

5.23

55.07

-50.00

-90.50%

Opening Cash & Cash Equivalents

500.34

134.13

366.00

273.03%

Cash & Cash Equivalent on Amalgamation / Take over / Merger

0.00

0.00%

Cash & Cash Equivalent of Subsidiaries under liquidations

0.00

0.00%

Translation adjustment on reserves / op cash balances foreign subsidiaries

0.00

0.00%

Effect of Foreign Exchange Fluctuations

0.00

0.00%

Closing Cash & Cash Equivalent

505.57

189.2

316.00

167.21%

Cash Flow - Snapshot (Standalone) - Mar'24

YoY Growth in year ended Mar 2024 is -52.19% vs -42.17% in Mar 2023

Mar'24

Mar'23

Change(%)

Cash Flow from Operating Activities

27.87

58.29

-52.19%